113 related articles for article (PubMed ID: 37741072)
1. Pharmacokinetic study of Tdp1 inhibitor resulted in a significant increase in antitumor effect in the treatment of Lewis lung carcinoma in mice by its combination with topotecan.
Okhina AA; Kornienko TE; Rogachev AD; Luzina OA; Popova NA; Nikolin VP; Zakharenko AL; Dyrkheeva NS; Pokrovsky AG; Salakhutdinov NF; Lavrik OI
J Pharm Biomed Anal; 2023 Nov; 236():115731. PubMed ID: 37741072
[TBL] [Abstract][Full Text] [Related]
2. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI
Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585
[TBL] [Abstract][Full Text] [Related]
3. The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.
Nikolin VP; Popova NA; Kaledin VI; Luzina OA; Zakharenko AL; Salakhutdinov NF; Lavrik OI
Clin Exp Metastasis; 2021 Oct; 38(5):431-440. PubMed ID: 34370156
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma].
Dyrkheeva NS; Zakharenko AL; Novoselova ES; Chepanova AA; Popova NA; Nikolin VP; Luzina OA; Salakhutdinov NF; Ryabchikova EI; Lavrik OI
Mol Biol (Mosk); 2021; 55(2):312-317. PubMed ID: 33871444
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the Clastogenic Effects of Topotecan In Vivo by Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Zhanataev AK; Kulakova AV; Luzina OA; Khomenko TM; Volcho KP; Salakhutdinov NF; Durnev AD
Bull Exp Biol Med; 2024 Jul; ():. PubMed ID: 38954304
[TBL] [Abstract][Full Text] [Related]
6. Development of an LC-MS/MS-based method for quantification and pharmacokinetics study on SCID mice of a dehydroabietylamine-adamantylamine conjugate, a promising inhibitor of the DNA repair enzyme.
Okhina AA; Rogachev AD; Kovaleva KS; Yarovaya OI; Khotskina AS; Zavyalov EL; Vatsadze SZ; Pokrovsky AG; Salakhutdinov NF
J Pharm Biomed Anal; 2023 Sep; 234():115507. PubMed ID: 37331915
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.
Kornienko TE; Chepanova AA; Zakharenko AL; Filimonov AS; Luzina OA; Dyrkheeva NS; Nikolin VP; Popova NA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279210
[TBL] [Abstract][Full Text] [Related]
8. Stability Study, Quantification Method and Pharmacokinetics Investigation of a Coumarin-Monoterpene Conjugate Possessing Antiviral Properties against Respiratory Syncytial Virus.
Nemolochnova AG; Rogachev AD; Salnikova OP; Khomenko TM; Volcho KP; Yarovaya OI; Fatianova AV; Pokrovsky AG; Salakhutdinov NF
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145379
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma.
Koldysheva EV; Men'shchikova AP; Lushnikova EL; Popova NA; Kaledin VI; Nikolin VP; Zakharenko AL; Luzina OA; Salakhutdinov NF; Lavrik OI
Bull Exp Biol Med; 2019 Mar; 166(5):661-666. PubMed ID: 30903487
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor.
Dyrkheeva NS; Malakhova AA; Zakharenko AL; Okorokova LS; Shtokalo DN; Pavlova SV; Medvedev SP; Zakian SM; Nushtaeva AA; Tupikin AE; Kabilov MR; Khodyreva SN; Luzina OA; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982223
[TBL] [Abstract][Full Text] [Related]
11. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models.
Zakharenko AL; Luzina OA; Sokolov DN; Kaledin VI; Nikolin VP; Popova NA; Patel J; Zakharova OD; Chepanova AA; Zafar A; Reynisson J; Leung E; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Eur J Med Chem; 2019 Jan; 161():581-593. PubMed ID: 30396105
[TBL] [Abstract][Full Text] [Related]
12. Biostability study, quantitation method and preliminary pharmacokinetics of a new antifilovirus agent based on borneol and 3-(piperidin-1-yl)propanoic acid.
Rogachev AD; Putilova VP; Zaykovskaya AV; Yarovaya OI; Sokolova AS; Fomenko VV; Pyankov OV; Maksyutov RA; Pokrovsky AG; Salakhutdinov NF
J Pharm Biomed Anal; 2021 May; 199():114062. PubMed ID: 33862506
[TBL] [Abstract][Full Text] [Related]
13. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.
Chernyshova IA; Zakharenko AL; Kurochkin NN; Dyrkheeva NS; Kornienko TE; Popova NA; Nikolin VP; Ilina ES; Zharkov TD; Kupryushkin MS; Oslovsky VE; Drenichev MS; Lavrik OI
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615517
[TBL] [Abstract][Full Text] [Related]
14. Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies.
Awosemo O; Neelakantan H; Watowich S; Ma J; Wu L; Chow DS; Liang D
J Pharm Biomed Anal; 2021 Sep; 204():114255. PubMed ID: 34304009
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of curcumin diethyl disuccinate and its active metabolite curcumin in rat plasma by LC-MS/MS: Application of esterase inhibitors in the stabilization of an ester-containing prodrug.
Ratnatilaka Na Bhuket P; Niwattisaiwong N; Limpikirati P; Khemawoot P; Towiwat P; Ongpipattanakul B; Rojsitthisak P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():301-310. PubMed ID: 27595650
[TBL] [Abstract][Full Text] [Related]
17. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
19. LC-MS-MS-MS3 for the determination and quantification of ∆9-tetrahydrocannabinol and metabolites in blood samples.
Proença P; Teixeira HM; Martinho B; Monteiro C; Franco J; Corte-Real F
J Anal Toxicol; 2023 Sep; 47(7):606-614. PubMed ID: 37494426
[TBL] [Abstract][Full Text] [Related]
20. New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors.
Filimonov AS; Chepanova AA; Luzina OA; Zakharenko AL; Zakharova OD; Ilina ES; Dyrkheeva NS; Kuprushkin MS; Kolotaev AV; Khachatryan DS; Patel J; Leung IKH; Chand R; Ayine-Tora DM; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2019 Oct; 24(20):. PubMed ID: 31619021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
